Additionally, we confirmed that siRNA-mediated knockdown of CLPTM1L could be a new approach for sensitizing NSCLC cells to IR in vitro (Additional file 1: Fig. S6C–E). This evidence concerns the gene CLPTM1L and non-small cell lung carcinoma.